Ubiquitination Is Essential for Avibirnavirus Replication by Supporting VP1 Polymerase Activity.


Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
01 02 2019
Historique:
received: 25 10 2018
accepted: 28 10 2018
pubmed: 16 11 2018
medline: 9 11 2019
entrez: 16 11 2018
Statut: epublish

Résumé

Ubiquitination is critical for several cellular physical processes. However, ubiquitin modification in virus replication is poorly understood. Therefore, the present study aimed to determine the presence and effect of ubiquitination on polymerase activity of viral protein 1 (VP1) of avibirnavirus. We report that the replication of avibirnavirus is regulated by ubiquitination of its VP1 protein, the RNA-dependent RNA polymerase of infectious bursal disease virus (IBDV).

Identifiants

pubmed: 30429342
pii: JVI.01899-18
doi: 10.1128/JVI.01899-18
pmc: PMC6340032
pii:
doi:

Substances chimiques

Ubiquitin 0
VP1 protein, infectious bursal disease virus 0
Viral Structural Proteins 0
RNA-Dependent RNA Polymerase EC 2.7.7.48

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2019 Wu et al.

Références

J Virol. 2003 Feb;77(4):2459-68
pubmed: 12551984
J Virol. 2016 Nov 14;90(23):10906-10914
pubmed: 27681127
J Virol. 2013 Aug;87(16):8993-9007
pubmed: 23741000
J Gen Virol. 2004 Aug;85(Pt 8):2221-2229
pubmed: 15269362
J Gen Virol. 2014 Apr;95(Pt 4):888-897
pubmed: 24431234
J Virol. 2017 Aug 24;91(18):
pubmed: 28679761
J Gen Virol. 1995 Feb;76 ( Pt 2):437-43
pubmed: 7844565
J Virol. 2005 Oct;79(19):12253-63
pubmed: 16160151
J Virol. 2017 Jan 18;91(3):
pubmed: 27881656
Virology. 1999 Sep 15;262(1):190-9
pubmed: 10489352
Autophagy. 2015;11(3):503-15
pubmed: 25714412
Nature. 2011 Mar 31;471(7340):633-6
pubmed: 21455180
J Biol Chem. 2015 Mar 27;290(13):8500-10
pubmed: 25583988
Science. 2014 Oct 24;346(6208):473-7
pubmed: 25342804
J Virol. 2001 Nov;75(22):10815-28
pubmed: 11602723
Mol Immunol. 2009 Jun;46(10):1964-9
pubmed: 19361862
J Virol. 2018 May 14;92(11):
pubmed: 29514908
Arch Virol. 2004 Nov;149(11):2245-60
pubmed: 15503210
EMBO J. 2010 Nov 17;29(22):3879-90
pubmed: 20924359
PLoS Pathog. 2015 Jun 09;11(6):e1004960
pubmed: 26057645
PLoS One. 2015 Jun 05;10(6):e0128828
pubmed: 26046798
Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17516-21
pubmed: 24101521
Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13069-74
pubmed: 11087861
J Virol. 1979 Sep;31(3):584-9
pubmed: 229240
J Virol. 2014 Mar;88(6):3103-13
pubmed: 24371060
Nat Rev Mol Cell Biol. 2015 May;16(5):322-4
pubmed: 25907614
Nat Rev Mol Cell Biol. 2011 Jun 23;12(7):439-52
pubmed: 21697901
Nat Rev Microbiol. 2014 Jun;12(6):399-413
pubmed: 24801936
J Virol. 2018 Jan 2;92(2):
pubmed: 29093101
Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):12945-7
pubmed: 11087848
J Virol. 2002 Nov;76(22):11301-11
pubmed: 12388690
Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13057-62
pubmed: 11087859
PLoS Pathog. 2008 Jun 06;4(6):e1000085
pubmed: 18535660
J Virol. 2015 Nov;89(21):11165-8
pubmed: 26311889
Mol Cell Proteomics. 2008 Mar;7(3):612-25
pubmed: 18056921
J Virol. 2002 Oct;76(20):10346-55
pubmed: 12239311
J Virol. 2012 Apr;86(7):3474-85
pubmed: 22258249
Proc Natl Acad Sci U S A. 2007 May 1;104(18):7385-90
pubmed: 17456597
J Virol. 2012 Feb;86(3):1328-38
pubmed: 22114330
Virus Res. 2008 Sep;136(1-2):146-51
pubmed: 18562033
J Virol. 2002 Mar;76(5):2393-402
pubmed: 11836417
J Virol. 2013 Apr;87(8):4523-33
pubmed: 23408607
Virology. 2013 Jun 5;440(2):204-9
pubmed: 23537958
Nat Cell Biol. 2016 Mar;18(3):291-302
pubmed: 26900751
J Virol. 1997 Jan;71(1):325-30
pubmed: 8985353
Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20540-5
pubmed: 18077388
Nature. 2009 Mar 26;458(7237):430-7
pubmed: 19325622
Nat Rev Mol Cell Biol. 2014 Aug;15(8):503-8
pubmed: 25027653
Virology. 2009 Dec 5;395(1):87-96
pubmed: 19801157
J Mol Biol. 2009 Feb 27;386(3):891-901
pubmed: 19063900
Immunity. 2016 Sep 20;45(3):555-569
pubmed: 27637147
Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13063-8
pubmed: 11087860
Arch Virol. 2003 Apr;148(4):723-44
pubmed: 12664296

Auteurs

Huansheng Wu (H)

MOA Key Laboratory of Animal Virology, Department of Veterinary Medicine, Zhejiang University, Hangzhou, China.

Liuyuan Shi (L)

MOA Key Laboratory of Animal Virology, Department of Veterinary Medicine, Zhejiang University, Hangzhou, China.

Yina Zhang (Y)

MOA Key Laboratory of Animal Virology, Department of Veterinary Medicine, Zhejiang University, Hangzhou, China.

Xiran Peng (X)

MOE International Joint Collaborative Laboratory for Animal Health and Food Safety, Institute of Immunology and College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, China.

Tuyuan Zheng (T)

MOE International Joint Collaborative Laboratory for Animal Health and Food Safety, Institute of Immunology and College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, China.

Yahui Li (Y)

MOE International Joint Collaborative Laboratory for Animal Health and Food Safety, Institute of Immunology and College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, China.

Boli Hu (B)

MOE International Joint Collaborative Laboratory for Animal Health and Food Safety, Institute of Immunology and College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, China.

Xiaojuan Zheng (X)

MOA Key Laboratory of Animal Virology, Department of Veterinary Medicine, Zhejiang University, Hangzhou, China.

Jiyong Zhou (J)

MOA Key Laboratory of Animal Virology, Department of Veterinary Medicine, Zhejiang University, Hangzhou, China jyzhou@zju.edu.cn.
Collaborative Innovation Center and State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, First Affiliated Hospital, Zhejaing University, Hangzhou, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH